Category Archives: News and Events

BriaCell’s Bria-OTS+(TM) Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal
August 26, 2025

Data from BriaCell and the US National Cancer Institute (NCI) support the cancer cell killing ...

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+(TM) in Prostate Cancer
August 25, 2025

US$2,054,651 non-dilutive grant from the US National Cancer Institute to complete manufacturing of Bria-Pros+ TM clinical supply ...

BriaCell Announces Proposed Effective Date of Share Consolidation
August 21, 2025

PHILADELPHIA and VANCOUVER, British Columbia, Aug. 21, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell Selected for MSK’s 2025 Therapeutics Accelerator Program for Bria-OTS+(TM) for Cancer
August 13, 2025

PHILADELPHIA and VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, ...

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study
July 31, 2025

PHILADELPHIA and VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell Awarded New Zealand Patent for its Whole Cell Technology
July 30, 2025

PHILADELPHIA and VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell’s Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents
July 29, 2025

TILsRx platform designed to overcome immune suppression and T cell exhaustion to activate tumor-infiltrating lymphocytes ...

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025
July 25, 2025

PHILADELPHIA and VANCOUVER, British Columbia, July 25, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell Therapeutics Announces Closing of $15 million Public Offering
July 16, 2025

PHILADELPHIA and VANCOUVER, British Columbia, July 16, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell Therapeutics Announces Pricing of $15 million Public Offering
July 15, 2025

PHILADELPHIA and VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

Skip to content